Real‐world outcomes of daratumumab, bortezomib, thalidomide and dexamethasone (Dara‐VTd) induction and lenalidomide maintenance in transplant‐eligible multiple myeloma

Edvan Q. Crusoé, Glaciano Ribeiro, João Tadeu D. Souto Filho, Jayr Schmidt Filho, Natalia Schutz, Milton A. F. Aranha, Abel Costa, Abrahao Hallack, Fernando V. Pericole, Juliana S. Lima, Breno Gusmão, Eduardo Flávio O. Ribeiro, Jorge P. Vaz, Rosane Bittencourt, Rafael Cunha, Danielle Ovigli, Luiza Berg, Ederson R. Mattos, Angelo Maiolino, Vania Hungria, Unknown

Open source

DOI: 10.1111/bjh.70775
Published: 2026-08-27
Container: British Journal of Haematology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/bjh.70775,
  title = {Real‐world outcomes of daratumumab, bortezomib, thalidomide and dexamethasone (Dara‐VTd) induction and lenalidomide maintenance in transplant‐eligible multiple myeloma},
  author = {Edvan Q. Crusoé and Glaciano Ribeiro and João Tadeu D. Souto Filho and Jayr Schmidt Filho and Natalia Schutz and Milton A. F. Aranha and Abel Costa and Abrahao Hallack and Fernando V. Pericole and Juliana S. Lima and Breno Gusmão and Eduardo Flávio O. Ribeiro and Jorge P. Vaz and Rosane Bittencourt and Rafael Cunha and Danielle Ovigli and Luiza Berg and Ederson R. Mattos and Angelo Maiolino and Vania Hungria and Unknown},
  year = {2026},
  journal = {British Journal of Haematology},
  doi = {10.1111/bjh.70775},
  url = {https://doi.org/10.1111/bjh.70775}
}

RIS

TY  - JOUR
TI  - Real‐world outcomes of daratumumab, bortezomib, thalidomide and dexamethasone (Dara‐VTd) induction and lenalidomide maintenance in transplant‐eligible multiple myeloma
AU  - Edvan Q. Crusoé
AU  - Glaciano Ribeiro
AU  - João Tadeu D. Souto Filho
AU  - Jayr Schmidt Filho
AU  - Natalia Schutz
AU  - Milton A. F. Aranha
AU  - Abel Costa
AU  - Abrahao Hallack
AU  - Fernando V. Pericole
AU  - Juliana S. Lima
AU  - Breno Gusmão
AU  - Eduardo Flávio O. Ribeiro
AU  - Jorge P. Vaz
AU  - Rosane Bittencourt
AU  - Rafael Cunha
AU  - Danielle Ovigli
AU  - Luiza Berg
AU  - Ederson R. Mattos
AU  - Angelo Maiolino
AU  - Vania Hungria
AU  - Unknown
PY  - 2026
JO  - British Journal of Haematology
DO  - 10.1111/bjh.70775
UR  - https://doi.org/10.1111/bjh.70775
ER  -

APA

Crusoé, E. Q., Ribeiro, G., Filho, J. T. D. S., Filho, J. S., Schutz, N., Aranha, M. A. F., Costa, A., Hallack, A., Pericole, F. V., Lima, J. S., Gusmão, B., Ribeiro, E. F. O., Vaz, J. P., Bittencourt, R., Cunha, R., Ovigli, D., Berg, L., Mattos, E. R., Maiolino, A., Hungria, V., & Unknown (2026). Real‐world outcomes of daratumumab, bortezomib, thalidomide and dexamethasone (Dara‐VTd) induction and lenalidomide maintenance in transplant‐eligible multiple myeloma. British Journal of Haematology. https://doi.org/10.1111/bjh.70775

Source records

crossref · retrieved 2026-09-26T22:50:01.848Z